ADMA Biologics Inc
ADMA
NASDAQ
Biotechnology
$9.47
USD
+0.06 (+0.64%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $2.19B
Volume 1.3M
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
VRDN | Viridian Therapeutics Inc | $2.48B | - | +23220.3% | - | |
PGEN | Precigen Inc | $2.33B | - | +1875.0% | - | |
PVLA | Palvella Therapeutics Inc | $2.24B | - | -97.2% | - | |
ADMA | ADMA Biologics Inc | $2.19B | 12.97 | +8.0% | - | |
STOK | Stoke Therapeutics Inc | $2.04B | - | -86.2% | - | |
AGIO | Agios Pharmaceuticals Inc | $2.00B | - | +140.6% | - | |
ZBIO | Zenas Biopharma Inc | $2.00B | - | - | - | |
TSHA | Taysha Gene Therapies Inc | $1.95B | - | +3.4% | - | |
GENB | Generate Biomedicines Inc | $1.89B | - | - | - |
Top Peer by Growth
Viridian Therapeutics Inc
+23220.3% YoY Revenue
Lowest P/E Ratio
ADMA Biologics Inc
12.97x P/E
Best 1-Year Return
Palvella Therapeutics Inc
+250.7% Return